JP2015143248A5 - - Google Patents

Download PDF

Info

Publication number
JP2015143248A5
JP2015143248A5 JP2015057637A JP2015057637A JP2015143248A5 JP 2015143248 A5 JP2015143248 A5 JP 2015143248A5 JP 2015057637 A JP2015057637 A JP 2015057637A JP 2015057637 A JP2015057637 A JP 2015057637A JP 2015143248 A5 JP2015143248 A5 JP 2015143248A5
Authority
JP
Japan
Prior art keywords
unit dose
dha
pharmaceutical composition
composition
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015057637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015143248A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015143248A publication Critical patent/JP2015143248A/ja
Publication of JP2015143248A5 publication Critical patent/JP2015143248A5/ja
Pending legal-status Critical Current

Links

JP2015057637A 2009-02-02 2015-03-20 認知機能改善および心拍数低下のための方法 Pending JP2015143248A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14931009P 2009-02-02 2009-02-02
US61/149,310 2009-02-02
US18354809P 2009-06-02 2009-06-02
US61/183,548 2009-06-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011548414A Division JP2012516852A (ja) 2009-02-02 2010-02-02 認知機能改善および心拍数低下のための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018073345A Division JP2018104477A (ja) 2009-02-02 2018-04-05 認知機能改善および心拍数低下のための方法

Publications (2)

Publication Number Publication Date
JP2015143248A JP2015143248A (ja) 2015-08-06
JP2015143248A5 true JP2015143248A5 (enExample) 2015-12-24

Family

ID=42041547

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011548414A Withdrawn JP2012516852A (ja) 2009-02-02 2010-02-02 認知機能改善および心拍数低下のための方法
JP2015057637A Pending JP2015143248A (ja) 2009-02-02 2015-03-20 認知機能改善および心拍数低下のための方法
JP2018073345A Pending JP2018104477A (ja) 2009-02-02 2018-04-05 認知機能改善および心拍数低下のための方法
JP2019238726A Pending JP2020050675A (ja) 2009-02-02 2019-12-27 認知機能改善および心拍数低下のための方法
JP2022023007A Withdrawn JP2022059063A (ja) 2009-02-02 2022-02-17 認知機能改善および心拍数低下のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011548414A Withdrawn JP2012516852A (ja) 2009-02-02 2010-02-02 認知機能改善および心拍数低下のための方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018073345A Pending JP2018104477A (ja) 2009-02-02 2018-04-05 認知機能改善および心拍数低下のための方法
JP2019238726A Pending JP2020050675A (ja) 2009-02-02 2019-12-27 認知機能改善および心拍数低下のための方法
JP2022023007A Withdrawn JP2022059063A (ja) 2009-02-02 2022-02-17 認知機能改善および心拍数低下のための方法

Country Status (8)

Country Link
US (2) US20100203123A1 (enExample)
EP (2) EP2939671A1 (enExample)
JP (5) JP2012516852A (enExample)
CN (3) CN104042600A (enExample)
AU (2) AU2016201382A1 (enExample)
CA (1) CA2751275A1 (enExample)
HK (1) HK1202243A1 (enExample)
WO (1) WO2010088700A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
WO2012159092A2 (en) * 2011-05-19 2012-11-22 The Regents Of The University Of California Medical food for cognitive decline
US20130084272A1 (en) * 2011-09-29 2013-04-04 Philippe Perrin Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US9446141B2 (en) * 2013-03-15 2016-09-20 Genspera, Inc. Methods of producing cancer compounds
BR112016014262B1 (pt) 2013-12-20 2022-04-05 MARA Renewables Corporation Método para recuperar lipídeos de uma população de micro-organismos
TR201503136A2 (tr) * 2015-03-16 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dronedaron ve esansiyel yağ asitlerinin farmasötik kompozisyonları.
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
EP3559206B1 (en) 2016-12-22 2025-12-03 Mara Renewables Corporation Methods for producing biomass rich in dha, palmitic acid and protein using a eukaryotic microorganism
JP7101087B2 (ja) * 2018-09-05 2022-07-14 株式会社 伊藤園 軽度認知障害に対する緑茶成分の有効性評価方法
FR3092968B1 (fr) * 2019-02-22 2021-05-21 Microphyt Complement alimentaire
AU2020325063B2 (en) * 2019-08-08 2026-04-02 Swinburne University Of Technology Uses of long-chain polyunsaturated fatty acids
IL297000A (en) 2020-04-03 2022-12-01 Mara Renewables Corp Microbial oils with high levels of omega-3 fatty acids
DE102020115238A1 (de) * 2020-06-09 2021-12-09 Pm-International Ag Nahrungsergänzungsmittel und Nahrungsmittel
KR20220167321A (ko) * 2020-07-02 2022-12-20 페어 테라퓨틱스 (유에스), 인코포레이티드 디지털 치료 위약 및 샴을 생성 및 관리하기 위한 시스템, 방법 및 디바이스
CA3204546A1 (en) * 2021-01-15 2022-07-21 Cambridge Cognition Limited Methods and systems of identifying individuals for perioperative neurocognitive disorder and/or post-viral cognitive impairment
WO2024155781A1 (en) * 2023-01-18 2024-07-25 Bioventures, Llc Method of preventing and treating alzheimer's disease and related dementias with drugs inhibiting the interaction between 14-3-3g protein and hexokinase-1 protein
WO2025019424A1 (en) * 2023-07-14 2025-01-23 Dsm Ip Assets B.V. Microbial oils having high epa content and methods of making the same
WO2025100476A1 (ja) * 2023-11-10 2025-05-15 国立大学法人京都大学 生理機能改善用の組成物
JP2025079778A (ja) * 2023-11-10 2025-05-22 ダイドーグループホールディングス株式会社 生理機能改善用の組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
EP2140863A1 (en) * 1993-06-09 2010-01-06 Martek Biosciences Corporation Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of neurological disorders
ES2135756T3 (es) 1994-08-16 1999-11-01 Frische Gmbh Procedimiento para la obtencion de productos nativos no solubles en agua a partir de mezclas de sustancias con ayuda de la fuerza centrifuga.
WO1996033263A1 (en) * 1995-04-17 1996-10-24 JAPAN, represented by DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
JP3985035B2 (ja) * 1995-09-14 2007-10-03 独立行政法人産業技術総合研究所 (n−6)系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途
DE60012934T2 (de) 1999-02-26 2005-08-25 Martek Biosciences Corp. Verfahren zum Abtrennen von einem Docosahexaensäure enthaltenden Triglycerid aus einem Triglyceridgemisch
US6395778B1 (en) * 2000-01-11 2002-05-28 Omegatech, Inc. Process for making an enriched mixture of polyunsaturated fatty acid esters
KR101591834B1 (ko) 2000-01-19 2016-02-18 마텍 바이오싸이언스스 코포레이션 무용매 추출 방법
ATE395835T1 (de) 2000-04-12 2008-06-15 Westfalia Separator Gmbh Verfahren zur fraktionierung von öl- und polar lipid-enthaltenden rohstoffen
EP1392278A4 (en) 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPIDREICH FRACTION WITH STEARIDONIC ACID AND GAMMA LINOLIC ACID FROM PLANT SEEDS AND MICROBES
EP1392623A4 (en) 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
US9101151B2 (en) 2002-05-03 2015-08-11 Dsm Ip Assets B.V. High-quality lipids produced by enzymatic liberation from biomass
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
EP1845999A4 (en) * 2005-01-24 2010-09-22 Pronova Biocare As USE OF A DHA-CONTAINING FATTY ACID COMPOSITION FOR THE PRODUCTION OF A PHARMACEUTICAL OR FOOD PRODUCT FOR THE TREATMENT OF AMYLOSIS RELATED DISEASES
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
CA2645645C (en) * 2005-05-23 2015-07-14 Massachusetts Institute Of Technology Compositions containing pufa and methods of use thereof
KR20130101596A (ko) * 2005-07-08 2013-09-13 마텍 바이오싸이언스스 코포레이션 치매 및 치매-전단계와 관련된 용태의 치료를 위한 다중불포화 지방산
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
US20090023808A1 (en) 2007-06-29 2009-01-22 Martek Biosciences Corporation Production and Purification of Esters of Polyunsaturated Fatty Acids
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid

Similar Documents

Publication Publication Date Title
HRP20210686T1 (hr) Pripravci i postupci za liječenje moždanog udara kod subjekta na istodobnoj terapiji statinom
JP2015503590A5 (enExample)
JP2013521310A5 (enExample)
RU2020123679A (ru) Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания
JP2019048843A5 (enExample)
JP2016511753A5 (enExample)
HK1204272A1 (en) Methods of treating pediatric metabolic syndrome
JP2015503593A5 (enExample)
EP4338805A3 (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
PH12015502307A1 (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
JP2008540394A5 (enExample)
RU2018111327A (ru) Способ ингибирования всасывания и/или повышения выведения липидов с использованием d-псикозы
NZ727980A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
JP2015520235A5 (enExample)
JP2016501248A5 (enExample)
RU2018136872A (ru) Композиции, содержащие 15-oh эпк, и способы их применения
RU2013146517A (ru) Композиции и способы, пригодные для облегчения возрастных заболеваний
JP2014512351A5 (enExample)
RU2016129079A (ru) Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы
JP2016053065A5 (enExample)
WO2017077528A3 (en) Methods and pharmaceutical compositions for treatment of lung inflammation
JP2013507454A5 (enExample)
JP2016501249A5 (enExample)
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
RU2020101477A (ru) Фармацевтические композиции, содержащие дглк, и их применение